Acne-Derm

Quick links to important sections

Acne-Derm

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acne-Derm

Quick Facts

Property Description
Active ingredient Azelaic Acid (Saturated Dicarboxylic Acid)
Form Cream (Topical Preparation)
Pharmacological class Keratolytic and Comedolytic Agent
Common use Anti-acne agent
Origin Synthetic

Acne-Derm is a dermatological agent supplied as a topical preparation in the form of a cream, with Azelaic Acid as its single active ingredient. This compound is classified as a saturated dicarboxylic acid, produced synthetically for pharmaceutical use. The medication is a single-ingredient product, intended for direct application to the skin via the topical route of administration. The primary pharmacological class is that of a Keratolytic and Comedolytic Agent with Antimicrobial properties. This specific presentation as a cream differentiates it from alternative Azelaic Acid formulations (like gels) and is often positioned for adolescents and adults who may benefit from a more emollient base compared to drying alcoholic preparations.


How is Azelaic Acid Classified and What is its General Purpose?

Azelaic Acid is pharmacologically recognized as a non-antibiotic agent that provides multi-modal benefits by acting as an anti-acne treatment and an anti-inflammatory agent. Its general purpose is to offer skin stabilization by intervening in key processes that lead to the formation of blemishes.

The drug functions as a comedolytic agent by supporting the normalization of epidermal keratinization, which helps regulate how skin cells shed and prevents the buildup of material that causes pore blockages. Furthermore, the compound exhibits significant antimicrobial properties by suppressing the growth and activity of Propionibacterium acnes, the bacteria centrally involved in acne pathogenesis. Azelaic Acid is clinically recognized for its efficacy in regulating skin cell behavior and reducing inflammation. This dual mechanism ensures the medication addresses both the physical blockage and the subsequent bacterial and inflammatory response, which defines its overall general benefit, providing comprehensive support for skin prone to inflammatory lesions.

Regulatory References

  1. NIH MedlinePlus

What side effects are possible with Acne-Derm?

Possible Side Effects and Safety Information

The official safety profile for topical Azelaic Acid is predominantly characterized by application site reactions, which are classified by regulatory authorities based on their expected frequency. These local effects typically reflect the topical route of administration and are usually associated with the initial phase of use.


Frequency-Classified Adverse Reactions

The most commonly documented adverse events are those occurring at the site of application. According to official regulatory documents, these include:

  • Very Common (Affecting ge 1 in 10 users): Application site pruritus (itching), burning, and pain.
  • Common (Affecting ge 1 in 100 users): Application site erythema (redness), dryness, rash, and paraesthesia (tingling/numbness).

These initial skin reactions are generally noted to subside with continued use of the medication.


Serious Adverse Reactions and Safety Constraints

While the medication's risk profile is primarily local, the regulatory labels document the rare occurrence of more significant events categorized under Immune System Disorders. These include systemic hypersensitivity reactions, such as urticaria (hives) and angioedema, as well as the documented worsening of asthma.

Consistent with these risks, the product is contraindicated in individuals with known hypersensitivity to Azelaic Acid or any of the inactive ingredients. Furthermore, official safety instructions caution against contact with the eyes and mucous membranes. Regulatory data confirms that the safety profile for treating acne vulgaris in pediatric patients (ages 12-16) is consistent with that observed in adults.

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information

The official regulatory profile for topical Azelaic Acid indicates a low systemic intoxication risk, as the compound has very low systemic toxicity and systemic overdose is unlikely to occur. Overdose concerns primarily center on local effects resulting from misuse or accidental exposure.


Documented Manifestations and Required Actions

Manifestation / Context Official Mandate / Finding
Systemic Risk Acute systemic intoxication is unlikely; no specific antidote is known.
Excessive Topical Use May result in pronounced local irritation, requiring discontinuation of use and the institution of appropriate symptomatic therapy.
Accidental Eye Contact Potential for eye and mucous membrane irritation or iridocyclitis. The required procedure is to wash the eyes with large amounts of water.
Severe Reactions Hypersensitivity reactions (e.g., angioedema, dyspnea) require the user to seek immediate medical attention.

Connection to the Overall Overdose Profile

Regulatory documents define the overdose profile through its minimal systemic risk, explicitly stating that systemic intoxication is unlikely. This classification focuses official requirements on managing localized adverse events, such as pronounced skin irritation, and accidental exposures, such as contact with the eyes. Urgent medical attention is mandated only when severe systemic hypersensitivity reactions are suspected, requiring a response for the associated life-threatening symptoms, rather than for effects arising from the compound's systemic overdose.

Therapeutic Uses of Acne-Derm

Treating Inflamed Acne Lesions and Papulopustular Rosacea

Acne-Derm is commonly used for managing conditions characterized by periods of heightened symptoms related to skin inflammation. This medication is used for easing symptom clusters associated with mild-to-moderate Acne vulgaris and the inflammatory symptoms of papulopustular rosacea. The therapeutic domains it helps manage include inflammatory lesions (papules and pustules), non-inflammatory blemishes (blackheads and whiteheads), and symptoms of skin discoloration (post-inflammatory hyperpigmentation). This provides supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Persistent Symptoms Acne-Derm may be relevant in contexts involving recurrent or episodic manifestations, such as adult-onset acne or in managing residual marks.


Symptom Relief and Patient Benefits

Acne-Derm is applied across domains where additional symptomatic support is needed, such as in managing chronic issues that disrupt daily comfort. This generally helps address clusters of symptoms that may become intense, specifically by moderating the appearance of blemishes and supporting skin stability over time. The medication's relevance is often noted when addressing lingering brown and red marks that follow healing, and it contributes to improved comfort by supporting a more even skin tone. The medication may be part of symptomatic management in scenarios where short-term symptom stabilization and long-term maintenance are appropriate.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Acne-Derm?

This section details the officially documented eligibility and non-eligibility requirements for Acne-Derm (Azelaic Acid 20% cream) based on authoritative governmental regulatory documents.


Populations That Must Not Use Acne-Derm (Contraindicated)

Acne-Derm is contraindicated and must not be used by individuals with a known history of hypersensitivity or allergy to the active ingredient, Azelaic Acid, or to any of the other inactive components (excipients), such as benzoic acid or propylene glycol, found in the product.


Populations with Eligibility Restrictions

Population Group Eligibility Status and Restriction
Children under 12 years Not recommended; safety and efficacy have not been established in this age group. Use is established for patients 12 years and older.
Pregnant Women Use requires caution and should only occur if clearly needed, and after a medical assessment determines that the potential benefit outweighs the potential risk.
Lactating/Nursing Women Use requires caution. Infants must be prevented from coming into contact with any skin area that has been treated with the medicine.
Application Site Strictly for topical use on the skin of the face and/or trunk. Contact with the eyes, mouth, and other mucous membranes must be avoided.

All use must be strictly in accordance with these official eligibility rules to ensure proper clinical context.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Azelaic Acid (Acne-Derm) is primarily defined by its low systemic availability, which limits the potential for conventional drug-drug interactions.


Interaction Category Official Regulatory Classification
Systemic Risk Classification Low Systemic Risk. Systemic drug-drug interactions are considered clinically unlikely.
Exposure Modification Status None documented. Formal studies to evaluate systemic interaction with other medicines have not been conducted.
Interacting Medicinal Products None listed for systemic pharmacokinetic interaction.
Restriction Type Local and Symptomatic Constraints.

Official Interaction Statements

  • The regulatory prescribing information explicitly states that no formal studies have been performed to evaluate systemic interactions with other medicines. This is supported by pharmacokinetic data confirming that only approximately four percent of the topically applied dose is systemically absorbed, resulting in plasma concentrations that are not significantly higher than natural baseline levels.
  • Co-administration with topical alcoholic cleansers, tinctures, astringents, abrasives, or peeling agents is restricted to prevent the risk of additive local skin irritation.
  • The product labeling requires the avoidance of spicy foods, thermally hot foods and drinks, and alcoholic beverages. This constraint is necessary because these substances are officially documented to provoke erythema, flushing, and blushing, which are symptoms of the underlying condition the product treats.

The official interaction constraints are thus focused on administration rules to mitigate local pharmacodynamic effects and on symptomatic triggers for the patient's skin condition, rather than on systemic pharmacokinetic drug-drug interactions.

Mechanism of Action

The active ingredient, Azelaic Acid, acts by influencing three core biological processes within the skin.

1. Modulation of Keratinocyte Proliferation and Follicular Turnover

Azelaic Acid modulates the rate at which skin cells mature and shed by influencing certain mitochondrial enzymes. This action affects keratinocyte differentiation, which results in the maintenance of follicular canal patency.

2. Suppression of Microbial Count and Inflammatory Mediator Release

The drug exerts a bacteriostatic effect by interfering with the protein synthesis of C. acnes bacteria. Concurrently, it acts as a free radical scavenger and reduces the output of pro-inflammatory mediators. This mechanism results in a decreased C. acnes count and a reduced release of pro-inflammatory mediators within the tissue.

3. Inhibition of Melanin Synthesis (Tyrosinase Enzyme)

Azelaic Acid functions as an inhibitor of the tyrosinase enzyme, which is critical for melanin production. By targeting the enzymatic step in the melanogenesis pathway, the drug's action causes a reduction in the synthesis of post-inflammatory pigment in hyperactive melanocytes.

Dosage and Administration Information

How to Use Acne-Derm: Administration Guidelines

Acne-Derm (Azelaic Acid 20% cream) is designated for topical use only. Standard application involves applying a thin layer of the cream to the affected skin area twice daily, typically once in the morning and once in the evening.

Prior to each application, the affected skin must be thoroughly washed with a mild cleansing agent or plain water, then patted dry. The cream should be gently but thoroughly massaged into the affected area(s). Immediately following the application process, the hands must be washed. It is important to avoid the use of occlusive wrappings or dressings over the treated areas.

Treatment Duration and Specific Populations

The duration of therapy is variable, depending on the individual patient and the severity of the condition. While the full course of therapy requires continuous use over several months to achieve optimum results, improvement in inflammatory lesions generally becomes noticeable after 4 weeks of consistent application.

Administration is approved for patients 12 years of age and older. There are no specific dose adjustments for patients with renal or hepatic impairment.

Recent Clinical Evidence

Research evidence / Overview of studies for Acne-Derm


Evidence for Acne Vulgaris (Papulopustular and Inflammatory)

The research base for Azelaic Acid, the active ingredient in Acne-Derm, includes numerous randomized controlled trials (RCTs) conducted over short to intermediate time frames. These studies were used in research exploring how symptoms change over time for individuals with mild-to-moderate inflammatory acne. Research examined outcomes related to inflammatory or irritative states by measuring inflammatory and non-inflammatory lesion counts. Findings describe patterns observed in the studies, often indicating differences in lesion counts between the active cream and a plain, inactive vehicle (placebo) over the typical 12-week study period. Long-term effects are not fully established; follow-up durations were limited in many core trials.


Evidence for Papulopustular Rosacea

Azelaic Acid was evaluated in a similar set of short-to-intermediate term RCTs for conditions characterized by fluctuating or episodic manifestations, specifically the inflammatory symptoms of papulopustular rosacea. The main research outcomes monitored were the count of inflammatory lesions (papules and pustules) and the degree of facial redness (erythema). Trials monitored patterns related to lesion count reduction when comparing the active cream with the vehicle. Research remains uncertain regarding outcomes for certain rosacea symptoms, such as telangiectasia (visible blood vessels), and is less clear on outcomes for those with the most severe forms.


What Is Still Uncertain About the Research

Comparative evidence is lacking in some key areas, particularly direct head-to-head comparisons against some other topical combination products used for acne. While the evidence quality varies across studies, a common limitation is that follow-up durations were limited, leaving long-term effects unestablished regarding sustained changes in inflammatory lesion counts or the long-term changes in skin pigmentation. Research provides context but not individual predictions; study results reflect the specific conditions under which they were conducted.

Frequently Asked Questions (FAQ)

Common questions about Acne-Derm (FAQ)

Q: Is it normal for acne to temporarily appear worse when first starting Acne-Derm?

Regulatory documents state that common skin reactions like burning, itching, or irritation at the application site are frequently reported and typically decrease with continued use. While a temporary worsening of acne lesions itself is not usually listed as an expected side effect, the presence of these initial irritations is a known reaction documented in regulatory materials.

Q: Does Acne-Derm cause sun sensitivity or increase the risk of sunburn?

Official product information advises minimizing direct sun exposure and using a broad-spectrum sunscreen during treatment. This advice is consistent with the general precautions noted in regulatory materials for topical skin treatments.

Q: What ingredients should I avoid in my skincare routine while using Acne-Derm?

Official prescribing information describes constraints against co-administration with topical agents like alcoholic cleansers, tinctures, astringents, abrasives, or peeling agents. This is intended to mitigate the risk of cumulative local skin irritation.

Q: What were the main findings regarding the efficacy of Acne-Derm in its pivotal clinical trials?

Findings from the clinical studies indicated a statistically significant reduction in inflammatory lesion counts when compared to the use of an inactive cream (vehicle). These studies typically tracked results over a 12-week period.

Q: What types of food or diet have an effect on the action of Acne-Derm? (High-level question)

The regulatory product labeling describes constraints against consuming spicy foods, hot foods, hot drinks, and alcoholic beverages. This is because these substances are officially documented to provoke symptoms like flushing and redness (erythema) related to the underlying skin condition.

Q: Are there any known effects of Acne-Derm on mood or mental well-being?

Central Nervous System (CNS) or psychiatric adverse events are not commonly listed as reported side effects in the official safety profiles for Acne-Derm. The safety information focuses predominantly on application site reactions.

Q: What are the descriptive safety considerations for using Acne-Derm during pregnancy?

Topical use during pregnancy is recommended only if a medical assessment clearly determines that the potential benefit outweighs the potential risk. This caution is based on animal studies showing evidence of embryotoxic effects when very high oral doses were administered.

Q: Does Acne-Derm treat existing acne scars or only active breakouts?

The drug is indicated for the topical treatment of acne vulgaris and its associated inflammatory lesions. Its mechanism includes inhibiting the enzyme that produces melanin, which can help reduce post-inflammatory hyperpigmentation (dark spots). However, it is not indicated for the treatment of textural scarring of the skin.

Q: How is Acne-Derm different from over-the-counter acne products?

Acne-Derm is a prescription drug with a specific multi-modal mechanism of action. This includes keratolytic (managing skin cell turnover), antimicrobial, and anti-melanin synthesis properties, which distinguish it from the primary action of most over-the-counter acne treatments.

Q: Is Acne-Derm the same type of medication as a topical retinoid?

No, Acne-Derm is classified as a saturated dicarboxylic acid. While it affects skin cell turnover, its multi-modal mechanism of action is different, and it is not classified as a retinoid drug in regulatory documents.

Q: Is Acne-Derm considered a long-term maintenance treatment?

Regulatory guidance notes that the full course of therapy requires continuous use over several months to achieve optimum results. Decisions about long-term use are typically based on ongoing assessment.

Q: Does Acne-Derm help with facial redness and inflammation?

Official information indicates the drug is approved for the treatment of inflammatory lesions associated with acne. Its mechanism involves reducing the output of pro-inflammatory mediators. The drug is also approved for treating the inflammatory symptoms of papulopustular rosacea.

Q: What is the longest someone can use Acne-Derm for according to studies?

The core clinical trials supporting the drug’s efficacy often tracked results over a period of 12 weeks. Regulatory guidance notes that the full course of therapy requires continuous use over several months.

Q: Are there any reported internal or systemic side effects from the skin application of Acne-Derm?

Due to the low systemic absorption rate (approximately four percent of the topical dose), the majority of reported effects are local. However, rare systemic hypersensitivity reactions like angioedema (swelling) and the documented worsening of asthma have been reported in post-marketing surveillance.

Q: Does Acne-Derm interact with common vitamin supplements?

Formal studies to evaluate systemic interactions with other medicines, including supplements, have not been conducted. Systemic drug-drug interactions are considered unlikely due to the very low systemic absorption rate of the drug.

Q: Are there official warnings about using physical exfoliants or scrubbing tools while on Acne-Derm?

Official labeling describes constraints against using topical abrasives while on Acne-Derm to prevent the risk of added local skin irritation. This caution applies to physical methods of exfoliation.

Q: Is there information regarding the use of Acne-Derm alongside cosmetic procedures like microdermabrasion?

The product labeling states constraints on the use of topical abrasives or peeling agents to mitigate local irritation. Official guidance suggests that the use of the drug in conjunction with cosmetic procedures be discussed with a healthcare provider.

Q: Can older adults or seniors use Acne-Derm without additional age-related considerations?

Official studies to date have not demonstrated geriatric-specific problems that would limit the use of the medication in patients 65 years of age and older. Official prescribing information does not specify any required changes in use for this population.

Q: Does Acne-Derm work differently on different skin tones or complexions?

The drug's mechanism of action includes the inhibition of the enzyme responsible for melanin production. Isolated cases of hypopigmentation (skin lightening) have been reported, and patients with dark complexions should observe for any early signs of skin color change.

Q: Are there official contraindications for people who have existing skin conditions like rosacea or perioral dermatitis?

The only contraindication listed in official documents is a known hypersensitivity or allergy to the active ingredient or any of the inactive components. The drug is, in fact, officially indicated for the inflammatory lesions of rosacea.

Q: Has Acne-Derm been specifically studied for its ability to prevent the formation of new acne lesions?

The clinical trials supporting approval focused on measuring the reduction of existing inflammatory and non-inflammatory lesions. The drug's mechanism involves supporting the normalization of skin cell shedding, which is a process relevant to the formation of new acne symptoms.

Q: Are there different versions of Acne-Derm that treat different types of acne?

Acne-Derm (Azelaic Acid) is available in different strengths and topical formulations that have been approved for use in the treatment of either acne or rosacea.

Q: Is it safe to apply makeup after using Acne-Derm?

Official patient counseling information states that once the medication has been applied and allowed to absorb into the skin, non-comedogenic cosmetics may be applied to the treated area.

Q: Does the product information mention any concerns about changes to body or facial hair?

Changes to body or facial hair, such as increased hair growth or hair loss, are not listed as common side effects. However, they are occasionally noted as very rare or post-marketing adverse events in some product profiles.

How should Acne-Derm be stored and disposed of?

How to Store and Dispose of Azelaic Acid Cream (Acne-Derm)

Official regulatory documents define specific conditions for storing and disposing of azelaic acid cream to maintain product stability and safety.


Required Storage Conditions

Classification Type Regulatory Statement
Temperature Store between 15°C and 30°C (59°F and 86°F). Do not freeze the product.
Protection Store away from excess heat, moisture, and direct light. Keep the container tightly closed and in its original packaging.
Child Safety Keep this medicine out of the sight and reach of children.

Disposal Instructions

Official guidance requires patients to ask a healthcare professional how to dispose of any medicine that is expired or no longer needed. Waste disposal must be carried out in accordance with federal, state, and local environmental control regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acne-Derm found in:

A-Z Index: